Daniel Bradbury, Director at Illumina, holds 13.29K shares in Castle Biosciences (Ticker: CSTL), holds 39.47K shares in Intercept Pharma (Ticker: ICPT), holds 25.00K shares in Nuvation Bio (Ticker: NUVB).
Daniel Bradbury latest transaction was an Uninformative Sell of $221.61K.
What was Daniel Bradbury's most profitable transaction?
Daniel Bradbury’s most profitable transaction was an Informative Buy of CORT stock on May 12, 2014. The return on the trade was 208.60%.
What is Daniel Bradbury's role in Illumina?
Daniel Bradbury's role in Illumina is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.